On Monday, Phio Pharmaceuticals Corp (NASDAQ: PHIO) was -9.27% drop from the session before settling in for the closing price of $2.05. A 52-week range for PHIO has been $0.97 – $9.79.
During the last 5-year period, the sales growth of Healthcare Sector giant was 66.30%. When this article was written, the company’s average yearly earnings per share was at 80.34%. With a float of $4.86 million, this company’s outstanding shares have now reached $5.73 million.
Phio Pharmaceuticals Corp (PHIO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Phio Pharmaceuticals Corp stocks. The insider ownership of Phio Pharmaceuticals Corp is 15.19%, while institutional ownership is 4.47%. The most recent insider transaction that took place on Jun 10 ’25, was worth 4,840. In this transaction Chairman, Pres & CEO of this company bought 2,000 shares at a rate of $2.42, taking the stock ownership to the 27,149 shares. Before that another transaction happened on Jun 10 ’25, when Company’s Director bought 2,500 for $2.42, making the entire transaction worth $6,050. This insider now owns 15,666 shares in total.
Phio Pharmaceuticals Corp (PHIO) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.54 earnings per share (EPS) during the time that was better than consensus figure (set at -4.14) by 2.6. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 64.39% during the next five years compared to 66.30% growth over the previous five years of trading.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Trading Performance Indicators
You can see what Phio Pharmaceuticals Corp (PHIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.34, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.10 in one year’s time.
Technical Analysis of Phio Pharmaceuticals Corp (PHIO)
Looking closely at Phio Pharmaceuticals Corp (NASDAQ: PHIO), its last 5-days average volume was 32.46 million, which is a jump from its year-to-date volume of 3.85 million. As of the previous 9 days, the stock’s Stochastic %D was 23.53%.
During the past 100 days, Phio Pharmaceuticals Corp’s (PHIO) raw stochastic average was set at 5.67%, which indicates a significant increase from 5.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.26 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.18, while its 200-day Moving Average is $2.04. However, in the short run, Phio Pharmaceuticals Corp’s stock first resistance to watch stands at $3.46. Second resistance stands at $5.06. The third major resistance level sits at $5.93. If the price goes on to break the first support level at $0.99, it is likely to go to the next support level at $0.12.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Key Stats
There are 5,727K outstanding shares of the company, which has a market capitalization of 10.65 million. As of now, sales total 0 K while income totals -7,150 K. Its latest quarter income was 0 K while its last quarter net income were -2,170 K.
